News & Articles
Selected Filters:
Commercial readiness in light of In Vitro Diagnostic Regulation (IVDR)
Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations
Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated
Single dose of Pfizer-BioNTech or Oxford-AstraZenca vaccine reduces infection rate by 65%, study finds
COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study
PsychLight sensor to enable discovery of new psychiatric drugs
Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse
Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Breaking down barriers: Willing precision omics to life
Dr. John Wilson explains how ProtiFi set out to develop solutions to all the problems preventing omics from delivering real clinical impact
New phase III data shows investigational antibody cocktail reduced hospitalization or death by 70% in non-hospitalized patients with COVID-19
Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days
IDBS launches Polar BioAnalysis
The launch extends the Polar BioPharma Lifecycle Management (BPLM) platform with best practices in preclinical drug qualification
Thermo Fisher Scientific completes FDA listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
Twist Bioscience and Biotia receive FDA EUA for hybridization-based NGS SARS-CoV-2 assay
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
Aptamer Group and Mologic partner to develop aptamer-based SARS-CoV-2 rapid antigen test
This partnership aims to offer an accelerated route to market rapid test technologies
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from FDA
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
Thermo Fisher Scientific collaborates with Protein Metrics to optimize data analysis in biopharma
Protein Metrics’ software solutions complement Thermo Fisher’s mass spectrometry systems to facilitate precise, reliable data processing and drive innovation
AstraZeneca provides an update on the safety of the COVID-19 vaccine
The monthly safety report will be made public on the European Medicines Agency website
Zymo Research receives 510(K) clearance for its collection/transport device for COVID-19
The first 510(K)-cleared transport medium for COVID-19 testing
Abbott introduces NeuroSphere™ Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the U.S.
Newly FDA-approved system allows a patient to both communicate with a physician and remotely receive stimulation settings in real time regardless of location
‘Backup’ pacemaker discovery in goats could have important implications for human hearts
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
Abbott receives FDA EUA for test that detects SARS-CoV-2 and three other respiratory infections
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
Novel pooled testing strategies can significantly increase ability to identify COVID-19 infections
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses